Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss

Chike Cao, Yinshi Ren, Adam S. Barnett, Anthony J. Mirando, Douglas Rouse, Se Hwan Mun, Kyung Hyun Park-Min, Amy L. McNulty, Farshid Guilak, Courtney M. Karner, Matthew J. Hilton, Geoffrey S. Pitt

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

While the prevalence of osteoporosis is growing rapidly with population aging, therapeutic options remain limited. Here, we identify potentially novel roles for CaV1.2 L-type voltage-gated Ca2+ channels in osteogenesis and exploit a transgenic gain-of-function mutant CaV1.2 to stem bone loss in ovariectomized female mice. We show that endogenous CaV1.2 is expressed in developing bone within proliferating chondrocytes and osteoblasts. Using primary BM stromal cell (BMSC) cultures, we found that Ca2+ influx through CaV1.2 activates osteogenic transcriptional programs and promotes mineralization. We used Prx1-, Col2a1-, or Col1a1-Cre drivers to express an inactivation-deficient CaV1.2 mutant in chondrogenic and/or osteogenic precursors in vivo and found that the resulting increased Ca2+ influx markedly thickened bone not only by promoting osteogenesis, but also by inhibiting osteoclast activity through increased osteoprotegerin secretion from osteoblasts. Activating the CaV1.2 mutant in osteoblasts at the time of ovariectomy stemmed bone loss. Together, these data highlight roles for CaV1.2 in bone and demonstrate the potential dual anabolic and anticatabolic therapeutic actions of tissue-specific CaV1.2 activation in osteoblasts.

Original languageEnglish (US)
JournalJCI Insight
Volume2
Issue number22
DOIs
StatePublished - Nov 16 2017
Externally publishedYes

Fingerprint

Osteogenesis
Estrogens
Osteoblasts
Bone and Bones
Osteoprotegerin
Ovariectomy
Osteoclasts
Stromal Cells
Chondrocytes
Osteoporosis
Cell Culture Techniques
Therapeutics
Population

Keywords

  • Bone Biology
  • Bone development
  • Calcium channels
  • Osteoclast/osteoblast biology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss. / Cao, Chike; Ren, Yinshi; Barnett, Adam S.; Mirando, Anthony J.; Rouse, Douglas; Mun, Se Hwan; Park-Min, Kyung Hyun; McNulty, Amy L.; Guilak, Farshid; Karner, Courtney M.; Hilton, Matthew J.; Pitt, Geoffrey S.

In: JCI Insight, Vol. 2, No. 22, 16.11.2017.

Research output: Contribution to journalArticle

Cao, C, Ren, Y, Barnett, AS, Mirando, AJ, Rouse, D, Mun, SH, Park-Min, KH, McNulty, AL, Guilak, F, Karner, CM, Hilton, MJ & Pitt, GS 2017, 'Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss', JCI Insight, vol. 2, no. 22. https://doi.org/10.1172/jci.insight.95512
Cao, Chike ; Ren, Yinshi ; Barnett, Adam S. ; Mirando, Anthony J. ; Rouse, Douglas ; Mun, Se Hwan ; Park-Min, Kyung Hyun ; McNulty, Amy L. ; Guilak, Farshid ; Karner, Courtney M. ; Hilton, Matthew J. ; Pitt, Geoffrey S. / Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss. In: JCI Insight. 2017 ; Vol. 2, No. 22.
@article{4daf938389d84e4f95af1c73b484efe5,
title = "Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss",
abstract = "While the prevalence of osteoporosis is growing rapidly with population aging, therapeutic options remain limited. Here, we identify potentially novel roles for CaV1.2 L-type voltage-gated Ca2+ channels in osteogenesis and exploit a transgenic gain-of-function mutant CaV1.2 to stem bone loss in ovariectomized female mice. We show that endogenous CaV1.2 is expressed in developing bone within proliferating chondrocytes and osteoblasts. Using primary BM stromal cell (BMSC) cultures, we found that Ca2+ influx through CaV1.2 activates osteogenic transcriptional programs and promotes mineralization. We used Prx1-, Col2a1-, or Col1a1-Cre drivers to express an inactivation-deficient CaV1.2 mutant in chondrogenic and/or osteogenic precursors in vivo and found that the resulting increased Ca2+ influx markedly thickened bone not only by promoting osteogenesis, but also by inhibiting osteoclast activity through increased osteoprotegerin secretion from osteoblasts. Activating the CaV1.2 mutant in osteoblasts at the time of ovariectomy stemmed bone loss. Together, these data highlight roles for CaV1.2 in bone and demonstrate the potential dual anabolic and anticatabolic therapeutic actions of tissue-specific CaV1.2 activation in osteoblasts.",
keywords = "Bone Biology, Bone development, Calcium channels, Osteoclast/osteoblast biology",
author = "Chike Cao and Yinshi Ren and Barnett, {Adam S.} and Mirando, {Anthony J.} and Douglas Rouse and Mun, {Se Hwan} and Park-Min, {Kyung Hyun} and McNulty, {Amy L.} and Farshid Guilak and Karner, {Courtney M.} and Hilton, {Matthew J.} and Pitt, {Geoffrey S.}",
year = "2017",
month = "11",
day = "16",
doi = "10.1172/jci.insight.95512",
language = "English (US)",
volume = "2",
journal = "JCI insight",
issn = "2379-3708",
publisher = "The American Society for Clinical Investigation",
number = "22",

}

TY - JOUR

T1 - Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss

AU - Cao, Chike

AU - Ren, Yinshi

AU - Barnett, Adam S.

AU - Mirando, Anthony J.

AU - Rouse, Douglas

AU - Mun, Se Hwan

AU - Park-Min, Kyung Hyun

AU - McNulty, Amy L.

AU - Guilak, Farshid

AU - Karner, Courtney M.

AU - Hilton, Matthew J.

AU - Pitt, Geoffrey S.

PY - 2017/11/16

Y1 - 2017/11/16

N2 - While the prevalence of osteoporosis is growing rapidly with population aging, therapeutic options remain limited. Here, we identify potentially novel roles for CaV1.2 L-type voltage-gated Ca2+ channels in osteogenesis and exploit a transgenic gain-of-function mutant CaV1.2 to stem bone loss in ovariectomized female mice. We show that endogenous CaV1.2 is expressed in developing bone within proliferating chondrocytes and osteoblasts. Using primary BM stromal cell (BMSC) cultures, we found that Ca2+ influx through CaV1.2 activates osteogenic transcriptional programs and promotes mineralization. We used Prx1-, Col2a1-, or Col1a1-Cre drivers to express an inactivation-deficient CaV1.2 mutant in chondrogenic and/or osteogenic precursors in vivo and found that the resulting increased Ca2+ influx markedly thickened bone not only by promoting osteogenesis, but also by inhibiting osteoclast activity through increased osteoprotegerin secretion from osteoblasts. Activating the CaV1.2 mutant in osteoblasts at the time of ovariectomy stemmed bone loss. Together, these data highlight roles for CaV1.2 in bone and demonstrate the potential dual anabolic and anticatabolic therapeutic actions of tissue-specific CaV1.2 activation in osteoblasts.

AB - While the prevalence of osteoporosis is growing rapidly with population aging, therapeutic options remain limited. Here, we identify potentially novel roles for CaV1.2 L-type voltage-gated Ca2+ channels in osteogenesis and exploit a transgenic gain-of-function mutant CaV1.2 to stem bone loss in ovariectomized female mice. We show that endogenous CaV1.2 is expressed in developing bone within proliferating chondrocytes and osteoblasts. Using primary BM stromal cell (BMSC) cultures, we found that Ca2+ influx through CaV1.2 activates osteogenic transcriptional programs and promotes mineralization. We used Prx1-, Col2a1-, or Col1a1-Cre drivers to express an inactivation-deficient CaV1.2 mutant in chondrogenic and/or osteogenic precursors in vivo and found that the resulting increased Ca2+ influx markedly thickened bone not only by promoting osteogenesis, but also by inhibiting osteoclast activity through increased osteoprotegerin secretion from osteoblasts. Activating the CaV1.2 mutant in osteoblasts at the time of ovariectomy stemmed bone loss. Together, these data highlight roles for CaV1.2 in bone and demonstrate the potential dual anabolic and anticatabolic therapeutic actions of tissue-specific CaV1.2 activation in osteoblasts.

KW - Bone Biology

KW - Bone development

KW - Calcium channels

KW - Osteoclast/osteoblast biology

UR - http://www.scopus.com/inward/record.url?scp=85062292693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062292693&partnerID=8YFLogxK

U2 - 10.1172/jci.insight.95512

DO - 10.1172/jci.insight.95512

M3 - Article

C2 - 29202453

AN - SCOPUS:85062292693

VL - 2

JO - JCI insight

JF - JCI insight

SN - 2379-3708

IS - 22

ER -